Zhengye Biotechnology Holding (ZYBT) Buildings (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Buildings for 3 consecutive years, with $22.1 million the latest figure, recorded in Q4 2025.

• Quarterly Buildings rose 3.79% year-over-year to $22.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.1 million (up 3.79% YoY) and the FY2025 annual result came in at $22.4 million, up 6.97% from the prior year.
• Buildings improved to $22.1 million in Q4 2025 per ZYBT's latest filing, from $21.3 million in the prior quarter.
• Over the last five years, Buildings for ZYBT reached as high as $22.1 million in Q4 2025 and fell as low as $21.1 million in Q4 2023.
• A 3-year average of $21.5 million and a median of $21.3 million in 2024 frame the typical range for Buildings.
• Annual changes were most pronounced in 2024 — Buildings grew 1.0% — and 2025, when it climbed 3.79%.
• Year by year, Buildings stood at $21.1 million in 2023, then gained by 1.0% to $21.3 million in 2024, then advanced by 3.79% to $22.1 million in 2025.
• According to Business Quant data, Buildings over the past three periods registered $22.1 million, $21.3 million, and $21.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.